Bioequivalence and Bioavailability Forum

Bioequivalence Limit, Power and interpretation Pharma_88 2020-09-22 13:27
- Bioequivalence Limit, Power and interpretation Helmut 2020-09-22 13:59
- Power and sensitivity analyses Helmut 2020-09-25 13:42

ICH M9 - reverse engineering? MSimoes 2020-09-16 16:01
- ICH M9 - reverse engineering? dshah 2020-09-17 06:46
  - ICH M9 - reverse engineering? MSimoes 2020-09-17 15:56

Retention for multicenter patient BABE study pash413 2020-09-06 17:43
- Retention for multicenter patient BABE study Achievwin 2020-09-14 14:21

EMA: Waiving MD study Helmut 2020-09-09 16:21
- EMA: Waiving MD study wienui 2020-09-09 17:43
  - EMA: Waiving MD study Helmut 2020-09-09 19:26
- PK model PharmCat 2020-09-10 20:12
  - Zero order helps often Helmut 2020-09-10 22:26
    - Zero order helps often PharmCat 2020-09-11 02:33
      - Distributed delay mittyri 2020-09-11 05:31

Design Pharma_88 2020-08-27 16:07
- Jurisdiction? Helmut 2020-08-27 17:32
  - Jurisdiction? Pharma_88 2020-08-31 10:26
    - EMA: ABEL for HVD(P)s, PK metrics Helmut 2020-08-31 12:21
      - EMA: ABEL for HVD(P)s, PK metrics Pharma_88 2020-09-08 09:05
        
        EMA: MD PK metrics Helmut 2020-09-08 17:25

Document Retention Period for Bioequivalence study Turkish Submission yatish gosai 2020-08-10 14:36
- Website of the Turkish Medicines and Medical Devices Agency Helmut 2020-08-10 15:15
- Document Retention Period for Bioequivalence study Turkish Submission Brus 2020-08-31 14:21
  - Document Retention Period: ICH = 2 Years, Nigeria = 5 Years, Turkey = ? Obinoscopy 2020-09-01 01:50
    - Document Retention Period: ICH = 2 Years, Nigeria = 5 Years, Turkey = ? Brus 2020-09-01 09:06
      - ICH = 2 Years after last approval based on study Ohlbe 2020-09-01 11:03

bioequivalence of vit D3 cholecalciferol khaoula 2020-08-18 12:41

long half-life and large variability martin 2020-07-29 16:57
- long half-life and large variability ElMaestro 2020-07-29 21:24
  - long half-life and large variability martin 2020-07-29 22:49
    - long half-life and large variability ElMaestro 2020-07-30 08:17
      - long half-life and large variability dshah 2020-08-10 06:18
- long half-life and large variability Achievwin 2020-08-12 15:22
  - long half-life and large variability Helmut 2020-08-12 15:53

Favipiravir Bioanalysis Ayman Rabayah 2020-08-11 08:44
- Homework Helmut 2020-08-11 11:35
  - Homework Ayman Rabayah 2020-08-12 07:56
    - “Shlonak” Helmut 2020-08-12 12:57

Retention period and quantity for Malaysian submission Sriramprasad 2020-07-18 09:06
- Retention period and quantity for Malaysian submission cakhatri 2020-08-10 08:04

USFDA guidance for petitioned ANDA shahajan baig 2020-07-20 21:50

CDISC in China? jag009 2020-07-16 19:46

Requirements for different pharmaceutical forms or dosages Mauricio Sampaio 2020-07-13 13:52
- Homework ;-) Helmut 2020-07-13 17:25

Transdermal Kelen 2020-06-29 18:51

steady state for modified release Kelen 2019-09-20 20:04
- steady state for modified release Helmut 2019-09-23 10:04
  - steady state for modified release apapanas 2020-06-24 14:25
    - Superposition principle Helmut 2020-06-24 14:38
      - Superposition principle apapanas 2020-06-24 15:32

Admin contact
21,086 posts in 4,398 threads, 1,468 registered users;
online 10 (0 registered, 10 guests [including 5 identified bots]).
Forum time: Tuesday 12:59 CEST (Europe/Vienna)

To know the history of science is to recognize the mortality
of any claim to universal truth. Evelyn Fox Keller

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz